ES2123546T3 - Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras. - Google Patents

Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.

Info

Publication number
ES2123546T3
ES2123546T3 ES92810863T ES92810863T ES2123546T3 ES 2123546 T3 ES2123546 T3 ES 2123546T3 ES 92810863 T ES92810863 T ES 92810863T ES 92810863 T ES92810863 T ES 92810863T ES 2123546 T3 ES2123546 T3 ES 2123546T3
Authority
ES
Spain
Prior art keywords
neuroprotectoral
preparation
compositions
quinoxaline
aminoalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92810863T
Other languages
English (en)
Inventor
Klaus Ehrenberger
Dominik Felix
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phafag AG
Original Assignee
Phafag AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phafag AG filed Critical Phafag AG
Application granted granted Critical
Publication of ES2123546T3 publication Critical patent/ES2123546T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE COMPUESTOS DE LA FORMULA DONDE R1 Y R2 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, METILO, ETILO, PROPILO, BUTILO O R1 Y R2 SON CONJUNTAMENTE CICLOALQUILO; R3 ES METOXI, ETOXI, HIDROXI, HIDROGENO, ALQUILO C1 ALQUIER SAL FARMACEUTICAMENTE ACEPTABLE CONSIGUIENTE, PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS NEUROPROTECTORAS, PARA LA PREVENCION O TRATAMIENTO DE NEUROTOXICIDAD POR MEDIACION DE RECEPTOR DE GLUTAMATO O INDUCIDA POR GLUTAMATO Y MOLESTIA FUNCIONALES DEL SISTEMA NERVIOSO CENTRAL.
ES92810863T 1991-11-15 1992-11-09 Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras. Expired - Lifetime ES2123546T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91119501 1991-11-15

Publications (1)

Publication Number Publication Date
ES2123546T3 true ES2123546T3 (es) 1999-01-16

Family

ID=8207340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92810863T Expired - Lifetime ES2123546T3 (es) 1991-11-15 1992-11-09 Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.

Country Status (5)

Country Link
US (1) US5563140A (es)
JP (1) JPH06239747A (es)
AT (1) ATE171374T1 (es)
DE (1) DE69227088T2 (es)
ES (1) ES2123546T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT784973E (pt) * 1995-10-10 2002-06-28 Pfizer Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
WO1999007302A1 (en) * 1997-08-07 1999-02-18 Natan Bauman Apparatus and method for an auditory stimulator
AT408837B (de) * 1998-06-19 2002-03-25 Phafag Ag Verwendung von caroverin und/oder caroverin. hydrochlorid zur herstellung von als antioxidantien wirkenden zusammensetzungen und/oder von neuroregenerativen zusammensetzungen
US20030045541A1 (en) * 2001-07-23 2003-03-06 Christopher Bruckner GABA-Receptor modulators with NMDA-Antagonistic activity
WO2004012705A1 (en) * 2002-07-31 2004-02-12 Phafag Ag A pharmaceutical formulation and its use in the treatment of inner ear diseases
US7751580B2 (en) * 2002-09-10 2010-07-06 Auditory Licensing Company, Llc Open ear hearing aid system
US7421086B2 (en) 2002-09-10 2008-09-02 Vivatone Hearing Systems, Llc Hearing aid system
US20050078843A1 (en) * 2003-02-05 2005-04-14 Natan Bauman Hearing aid system
CA2594963A1 (en) * 2005-01-24 2006-07-27 Neurosystec Corporation Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
WO2006096518A2 (en) * 2005-03-04 2006-09-14 Neurosystec Corporation Improved gacyclidine formulations
WO2007012064A2 (en) * 2005-07-20 2007-01-25 Cypress Bioscience, Inc. Prevention and treatment of hearing disorders
US8267905B2 (en) 2006-05-01 2012-09-18 Neurosystec Corporation Apparatus and method for delivery of therapeutic and other types of agents
US7803148B2 (en) * 2006-06-09 2010-09-28 Neurosystec Corporation Flow-induced delivery from a drug mass
JP2009544355A (ja) * 2006-07-20 2009-12-17 ニューロシステック コーポレイション 眼科薬物送達のためのデバイス、システム、および方法
JP2010511595A (ja) * 2006-07-31 2010-04-15 ニューロシステック コーポレイション 遊離塩基ガシクリジンナノ粒子
US20080065002A1 (en) * 2006-09-07 2008-03-13 Neurosystec Corporation Catheter for Localized Drug Delivery and/or Electrical Stimulation
KR101117129B1 (ko) 2009-09-14 2012-02-24 한국화학연구원 신규한 퀴녹살린 유도체 및 이를 포함하는 줄기세포의 신경세포로의 분화유도용 조성물
EP2522350B1 (de) 2011-05-12 2013-07-31 Immunopharm AG Verwendung der Wirkstoffkombination aus einem 1-Diethylaminoethyl-3-Chinoxalin-2-on Derivat und einem Oxysterol zur Durchbrechung von Resistenzen bei der Behandlung von Krebs und zur Erhöhung der Immunleistungsfähigkeit bei Krebs, bakteriellen und viralen Erkrankungen, Autoimmunerkrankungen, erhöhter Stress- und Umweltbelastung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE228204C (es) *
EP0032564A1 (de) * 1979-12-28 1981-07-29 Medichemie Ag Pharmazeutische Verwendung von Caroverin und/oder Caroverinsalzen sowie Caroverinsalze mit Xanthinderivat-Säureresten und Nicotinsäurerest
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases
US5037848A (en) * 1989-08-25 1991-08-06 Washington University Aryl-cycloalkyl-alkanolamines for treatment of epilepsy

Also Published As

Publication number Publication date
JPH06239747A (ja) 1994-08-30
ATE171374T1 (de) 1998-10-15
US5563140A (en) 1996-10-08
DE69227088T2 (de) 1999-06-02
DE69227088D1 (de) 1998-10-29

Similar Documents

Publication Publication Date Title
ES2123546T3 (es) Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
NO972910L (no) Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister
FI980341A0 (fi) 2-oksi-indolijohdannaisia
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
DE60041973D1 (de) Substituierte piperidin-verbindungen als modulatoren der chemokine receptor aktivität
ES2103479T3 (es) Derivados de anilida.
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
NO942953D0 (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
NO304379B1 (no) 11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater
ATE164848T1 (de) 4''-deoxyerythromycinderivate
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
DE60001586D1 (de) Diphenyl-piperidin derivate
RU94038255A (ru) Производные бензодиазепина, способ их получения, фармацевтическая композиция
AP9801377A0 (en) Tricyclic erythromycin derivatives.
ATE384708T1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren
ATE237614T1 (de) Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
ATE285771T1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
ES2194412T3 (es) Uso de derivados de hidantoina para la preparacion de un medicamento para el tratamiento de vasculitis resistente al tratamiento.
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
NZ225528A (en) Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions
AP9801235A0 (en) Erythromycin derivatives.
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 542689

Country of ref document: ES